Johnson & Johnson has kicked off a marketing application in the US for TAR-200 as a treatment for a form of bladder cancer, using a novel technology that releases the drug intravesically, or directly ...
VANCOUVER, BC / ACCESS Newswire / October 27, 2025 / Carcetti Capital Corp. (" Carcetti" or the "Company") is pleased to announce that it has filed a technical report prepared in accordance with ...
Apple’s DMA troubles in Europe continue, but a solution may be in sight The company is reportedly in the final stages of some kind of deal with European regulators under which it would be forced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback